CONTROL SET FOR THE BD PROBETEC (CT/GC) QX AMPLIFIED DNA ASSAYS
Report
- Report Number
- 1119779-2021-00283
- Event Type
- Malfunction
- Date Received
- February 10, 2021
- Date of Event
- December 14, 2020
- Report Date
- January 22, 2021
- Manufacturer
- BECTON, DICKINSON & CO. (SPARKS)
- Product Code
- LSL
- UDI-DI
- 00382904411251
- PMA / PMN Number
- K081825
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
(B)(4). INVESTIGATION SUMMARY: BD MOLECULAR QUALITY INITIATED INVESTIGATION ON THE CUSTOMER REPORT REGARDING SEVERAL INVALID CT/GC POSITIVE CONTROL RESULTS. QUALITY INVESTIGATION REQUIRED REVIEW OF THE BATCH HISTORY RECORDS AND FUNCTIONAL ANALYSIS OF RETENTION MATERIALS FROM THE CUSTOMERS REPORTED REAGENT BATCH AS WELL AS COMPLAINT TRENDING REVIEW. THE BATCH HISTORY RECORDS WERE REVIEWED AND NO DISCREPANCIES WERE NOTED. FUNCTIONAL ANALYSIS OF RETENTION MATERIALS PASSED WITH 100% POSITIVITY FOR CT AND GC. QUALITY WAS UNABLE TO DUPLICATE THE CUSTOMERS REPORTED FAILURE MODE. THERE ARE NO CURRENT COMPLAINT TRENDS AGAINST INVALID CT/GC POSITIVE CONTROL RESULTS ON THE VIPER XTR SYSTEM. BD MOLECULAR QUALITY WILL CONTINUE TO CLOSELY MONITOR FOR TRENDS ASSOCIATED WITH INVALID CT/GC POSITIVE CONTROL RESULTS.
IT WAS REPORTED THAT WHILE USING CONTROL SET FOR THE BD PROBETEC¿ (CT/GC) QX AMPLIFIED DNA ASSAYS 4 FALSE NEGATIVE RESULTS WERE OBTAINED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 203749 | CONTROL SET FOR THE BD PROBETEC (CT/GC) QX AMPLIFIED DNA ASSAYS | DNA REAGENTS, NEISSERIA | LSL | BECTON, DICKINSON & CO. (SPARKS) | 441125 | 0247078 | 00382904411251 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |